Description
Latin name
Slabicap
Packing
Bottle of 10 ml.
Pharmacological action
Slabikap – laxative. Reduces the absorption of electrolytes and water, enhances intestinal motility.
The active form of the drug, formed by hydrolysis under the influence of intestinal microorganisms, directly excites the nerve structures of the intestinal wall, as a result of which the intestinal contents are accelerated. The action occurs 10 to 12 hours after administration.
Pharmacokinetics of
After oral administration, it is not absorbed from the gastrointestinal tract and does not undergo hepatic-intestinal circulation.
Indications
Atonic constipation.
Regulation of the stool (hemorrhoids, proctitis, anal fissures).
Preparation for surgical operations, instrumental and radiological examinations.
Contraindications
hypersensitivity,
intestinal obstruction,
strangulated hernia,
acute inflammatory diseases of the abdominal organs.
peritonitis,
abdominal pain (of unknown origin),
severe dehydration,
bleeding from the gastrointestinal tract,
metrorrhagia,
cystitis,
spastic constipation,
childhood (up to 3 years),
.
Caution: lactation.
Use during pregnancy and lactation
Contraindicated in the first trimester of pregnancy. In the II and III trimesters of pregnancy and during breastfeeding, use only as directed by a doctor.
Composition
100 ml. drops for oral administration contain:
Active substances: sodium picosulfate in terms of anhydrous – 750 mg
Excipients: sorbitol (sorbitol), propylene glycol, water for injection – up to 100 ml.
Dosage and administration of
slabicap is prescribed orally before bedtime.
For adults, the initial dose is 10 drops, with persistent constipation – up to 30 drops. For children over 4 years of age, the initial dose is 5-8 drops. Depending on the effect obtained, the dose is increased or decreased in subsequent doses.
Do not use the drug daily for more than 10 days without medical supervision.
Side effects
Diarrhea,
abdominal pain,
dehydration,
imbalance,
weakness,
cramps,
lowering blood pressure.
Drug Interaction
Increased sensitivity to cardiac glycosides.
ACS and diuretics, when used with Slabicap, increase the risk of electrolyte disorders.
Broad spectrum antibiotics reduce the laxative effect of Slabicap.
Overdose
Symptoms: may increase side effects. In addition, chronic overdose may develop ischemia of the mucous membrane of the colon, secondary hyperaldosteronism, urolithiasis, lesions of renal tubules.
Treatment: gastric lavage, correction of water-electrolyte balance disorders, prescribe antispasmodics.
Storage conditions
The drug should be stored protected from light, out of reach of children at a temperature not exceeding 20 ° C.
Expiration
2 years.
Deystvuyuschee substances
Sodium pikosulfat
pharmacy leave terms without a prescription
Possible product names
Slabikap 7.5mg / ml Drops for oral administration 10ml Fl.-cap.
slobkap drops for oral administration 7.5 mg / ml, 10 ml
